*To the Editor:* The coronavirus disease 2019 (COVID-19) has been associated with several skin manifestations, including widespread urticaria, erythematous rash, and varicella-like exanthem.[@bib1] ^,^ [@bib2] Ischemic and ecchymotic acral lesions have also been described in patients with severe forms of COVID-19 as a manifestation of clotting disorders.[@bib3] Coincident with the COVID-19 pandemic, similar acral lesions have being described in healthy young patients.[@bib4] However, the clinical implication and relation to COVID-19 remains unclear.

We designed a retrospective study of general consultations from March 5 to April 15, 2020, in Spain. Inclusion criteria were the presence of skin lesions as the reason for the consultation, collection of clinical photographs, and informed consent. Exclusion criteria included nonacral skin lesions and lack of clinical data.

From 346 initial patients, 132 fulfilled selected criteria. Patients\' data are summarized in [Table I](#tbl1){ref-type="table"} . Mean age was 19.9 years (range, 1-56 years). Of the 132 patients, 54 (40.9%) had close contact with a patient with confirmed COVID-19, 28 (21.2%) had close contact with a health worker, and 19 (14.4%) were clinically diagnosed with COVID-19. None of the patients had COVID-19 pneumonia or specific medication. COVID-19 symptoms began in 16 patients before the skin lesions, with a mean latency time of 9.2 days (range, 3-30 days), and skin lesions in 3 patients started at the same time. Mean duration of the skin lesions was 8.7 days (range, 2-24 days).Table IClinical characteristics of patients with acroischemic lesionsCharacteristic[∗](#tbl1fnlowast){ref-type="table-fn"}Clinical pattern of acral lesionsTotal (N = 132)*P* value[†](#tbl1fndagger){ref-type="table-fn"}Chilblain-like (n = 95 \[72.0\])Erythema multiforme-like (n = 37 \[28.0\])Age, y23.4 (2-56)12.2 (1-29)19.9 (1-56)\<.001Sex.415 Male49 (51.6)22 (59.4)71 (53.8) Female46 (48.4)15 (40.6)61 (46.2)COVID-19 symptoms19 (25.0)6 (16.2)18 (13.6).618Location of skin lesions Hands33 (34.7)8 (21.6)41 (31.1).144 Feet73 (76.8)35 (94.6)108 (81.8).018Distribution of skin lesions Digital87 (91.6)33 (89.2)120 (90.9).738[‡](#tbl1fnddagger){ref-type="table-fn"} Dorsal23 (24.2)12 (32.4)35 (26.5).336 Ventral3 (3.2)15 (40.6)18 (13.6)\<.001 Heels/wrists12 (12.6)10 (27.0)22 (16.7).046 Other02 (5.4)2 (1.5).077[‡](#tbl1fnddagger){ref-type="table-fn"}Duration of skin lesions, d9.2 (3-24)7.4 (2-15)8.7 (2-24).019[^1][^2][^3]

In 11 patients, a real-time reverse-transcription polymerase chain reaction test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was performed from a nasopharyngeal swab, after the onset of skin lesions. The test result was positive in 2 patients (18.1%). Serologic assays were not performed.

After the clinical images were evaluated, we could describe 2 different patterns of acute acral lesions, which can overlap ([Table I](#tbl1){ref-type="table"}). The chilblain-like pattern, which was present in 95 patients (72.0%), is characterized by red-to-violet macules, plaques, and nodules, usually at the distal aspects of toes and fingers ([Fig 1,](#fig1){ref-type="fig"} *A-C*). The erythema multiforme-like pattern was present in 37 patients (28.0%) and is characterized by rounded erythematous macules and vesicles that tend to coalesce. Compared with classical erythema multiforme, individual lesions are smaller (\<1 cm diameter). It does not usually present typical targetoid lesions and tends to be less widespread ([Fig 2](#fig2){ref-type="fig"} , *A-C*). Only 2 of 37 patients (5.4%) also presented lesions at other sites of the body, including elbows, knees, and ears.Fig 1Chilblain-like acral lesions. **A**, Ecchymotic plaques and nodules with a bruising appearance over the distal aspects of toes. **B**, Confluent erythematous-violaceous diffuse plaques sparing some toes and the dorsal feet. **C**, Close-up view of the lateral and plantar aspects of toes.Fig 2Erythema multiforme-like acral lesions. **A**, Erosion and crust formation over dusky plaques in the dorsal aspects of digits. A Koebner phenomenon is present over the hallux valgus. **B**, Circular lesions, some of them with a targetoid appearance, over the plantar surface. **C**, Confluent vesicles over a dusky area.

Blood coagulation is altered in COVID-19 patients. Elevated levels of D-dimer and prothrombin time are associated with a poor prognosis.[@bib5] True ischemic acral lesions have been described in severely ill patients with COVID-19, manifesting a disseminated intravascular coagulation. There is an increasing concern about the clinical implications of acute acral lesions in asymptomatic or mildly symptomatic patients. The patients in this study did not develop COVID-19 pneumonia or any other complication. The latency time between COVID-19 symptoms and skin manifestations and the low positive rate for nasopharyngeal swabs suggest that it represents a late manifestation of SARS-CoV-2 infection. Whether the lesions represent a coagulation disorder or a hypersensitivity reaction is yet to be known.
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[^1]: Data are presented as the mean (range) or number (%).

[^2]: To compare a qualitative variable with a quantitative one, the Student *t* parametric test was used after assenting normality. To compare two qualitative variables, the χ^2^ test or Fisher exact test were used.

[^3]: Fischer\'s exact test was used.
